{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Buprenorphine%2FNaloxone+moderate+dose", "query": { "intervention": "Buprenorphine/Naloxone moderate dose" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 6, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-30T20:50:56.151Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06406400", "title": "Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Opioid Use Disorder" ], "interventions": [ { "name": "AZD4041", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" }, { "name": "Buprenorphine", "type": "DRUG" }, { "name": "Buprenorphine / Naloxone", "type": "DRUG" }, { "name": "Hydromorphone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 15, "start_date": "2024-05-13", "completion_date": "2024-07-31", "has_results": false, "last_update_posted_date": "2025-03-26", "last_synced_at": "2026-09-30T20:50:56.151Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06406400" }, { "nct_id": "NCT04219540", "title": "Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Opioid-use Disorder" ], "interventions": [ { "name": "XR-B (SUBLOCADETM)", "type": "DRUG" }, { "name": "XR-NTX", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 675, "start_date": "2021-01-07", "completion_date": "2025-02-28", "has_results": false, "last_update_posted_date": "2025-05-14", "last_synced_at": "2026-09-30T20:50:56.151Z", "location_count": 6, "location_summary": "New Haven, Connecticut • Baltimore, Maryland • Hanover, New Hampshire + 3 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Hanover", "state": "New Hampshire" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04219540" }, { "nct_id": "NCT06576843", "title": "INDV-6001 Multiple-Dose Pharmacokinetic Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Moderate to Severe Opioid Use Disorder" ], "interventions": [ { "name": "INDV-6001", "type": "DRUG" }, { "name": "Suboxone", "type": "DRUG" }, { "name": "Sublocade", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indivior Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 123, "start_date": "2024-09-17", "completion_date": "2026-01-21", "has_results": false, "last_update_posted_date": "2026-03-16", "last_synced_at": "2026-09-30T20:50:56.151Z", "location_count": 11, "location_summary": "San Diego, California • Miami Lakes, Florida • Chicago, Illinois + 8 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Flowood", "state": "Mississippi" }, { "city": "Marlton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06576843" }, { "nct_id": "NCT03015246", "title": "Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Heroin Dependence", "Opioid Use Disorder" ], "interventions": [ { "name": "Extended release morphine", "type": "DRUG" }, { "name": "Buprenorphine/Naloxone low dose", "type": "DRUG" }, { "name": "Buprenorphine/Naloxone moderate dose", "type": "DRUG" }, { "name": "Buprenorphine/Naloxone high dose", "type": "DRUG" }, { "name": "Active stressor", "type": "DRUG" }, { "name": "Placebo stressor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wayne State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 26, "start_date": "2016-12", "completion_date": "2020-08", "has_results": false, "last_update_posted_date": "2020-11-10", "last_synced_at": "2026-09-30T20:50:56.151Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03015246" }, { "nct_id": "NCT02161354", "title": "Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dental Pain" ], "interventions": [ { "name": "NTC-510 capsules", "type": "DRUG" }, { "name": "Placebo Capsules", "type": "DRUG" }, { "name": "NTC-510A Capsules", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NanoSHIFT LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 52, "start_date": "2014-06", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2017-06-23", "last_synced_at": "2026-09-30T20:50:56.151Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02161354" }, { "nct_id": "NCT07435077", "title": "Examining Analgesic Synergy and Efficacy in Trauma Care", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Opioid Use Disorder" ], "interventions": [ { "name": "Buprenorphine", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 282, "start_date": "2026-10", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-30T20:50:56.151Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07435077" } ] }